Back to Authors

Ritchie, Charles A

Mayo Clinic

Department of Vascular and Interventional Radiology, Mayo Clinic, Florida, USA.

Citations 3

Mechanical Thrombectomy for Cerebral Venous Sinus Thrombosis: 2-Dimensional Operative Video
Khatib, Ahmad G , Tatit, Rafael T , Kumar, Jeyan S. , Ritchie, Charles A, Tawk, Rabih G

Operative Neurosurgery | September 25, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1227/ons.0000000000002207 Get It

Renal artery injury during inferior vena cava filter removal with endobronchial forceps
Padula, Carlos A. , Lewis, Andrew R. , Frey, G. , McKinney, J. Mark , Paz‐Fumagalli, Ricardo , Ritchie, Charles , Devcic, Zlatko , Toskich, Beau B. , Frey, Gregory T, Ritchie, Charles A

JRSM Cardiovascular Disease | December 4, 2019 | Volume: 8 | Issue: No issue available | Pages: No page available

10.1177/2048004019893513 Get It

Retrieval of tip-embedded inferior vena cava filters using endobronchial forceps is a well-described technique. The tip of dorsally tilted filters may be in proximity to the right renal artery, increasing the risk of arterial injury during retrieval. We present one case that illustrates renal artery injury requiring emergent stent graft repair. The three subsequent cases illustrate techniques that avoid renal artery injury using a femoral and jugular approach with the assistance of an arterial fiducial wire. Renal artery injury is a potential complication during retrieval of filters using endobronchial forceps that can be prevented with careful planning.
Radiofrequency Ablation, Where It Stands in Interventional Radiology Today
Ritchie, Charles , Padula, Carlos A. , McKinney, J. Mark , Patel, Vipulkumar, Ritchie, Charles A, Padula, Carlos, Patel, Vipulkumar

Seminars in Interventional Radiology | December 2, 2019 | Volume: 36 | Issue: 05 | Pages: 398-404

10.1055/s-0039-1697945 Get It

AbstractRadiofrequency ablation (RFA) is one of the first developed minimally invasive definitive cancer therapies. The safety and efficacy of RFA is well documented and has led to its incorporation into multiple international societal guidelines. By expanding on the body of knowledge acquired during the clinical use of RFA, alternative ablative technologies have emerged and are successfully competing for locoregional therapy market share. The adaption of newer ablative technologies is leading to a rapid decline in the utilization of RFA by interventional radiologists despite the lack of proven superiority. In their 2010 article, Hong and Georgiades stated “… RFA is likely to remain the mainstay of ablations for small tumors until sufficient experience emerges for the widespread acceptance for alternative ablative modalities.” Within a decade of this publication, has this time arrived?